Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OMNICELL, INC. Director's Dealing 2018

Jul 17, 2018

31980_dirs_2018-07-17_7ae9b196-266b-4128-a357-a37396e33240.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2018-07-16

Reporting Person: JOHNSTON DAN S (EVP & Chief Legal & Admin)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-07-16 Common Stock M 3750 Acquired 43209 Direct
2018-07-16 Common Stock S 3750 $53.0467 Disposed 39459 Direct
2018-07-16 Common Stock M 2500 $0.00 Acquired 41959 Direct
2018-07-16 Common Stock S 2500 $53.0627 Disposed 39459 Direct
2018-07-16 Common Stock S 3463 $53.0601 Disposed 35996 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-07-16 Stock Options NQ (right to Buy) $25.08 M 3750 Disposed 2024-02-04 Common Stock (3750) Direct
2018-07-16 Stock Options NQ (right to Buy) $34.02 M 2500 Disposed 2025-02-06 Common Stock (2500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 39459 Direct

Footnotes

F1: The price reported in Column 4 is the average price of $53.0467. The sold price range was between $52.75 to $53.40. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The price reported in Column 4 is the average price of $53.0627. The sold price range was between $52.95 to $53.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.

F4: The price reported in Column 4 is the average price of $53.0601. The sold price range was between $52.75 to $53.45. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote